Seyffert, Jennifer, and William Steffes. “Vitiligo Following Alemtuzumab Therapy in Multiple Sclerosis: A Demonstration of Secondary Autoimmunity”. International Journal of Research in Dermatology 5, no. 4 (October 21, 2019): 882–884. Accessed October 12, 2025. https://www.ijord.com/index.php/ijord/article/view/777.